Clinical Trial Update: The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 2 clinical trial evaluating gemcitabine as maintenance therapy in patients with advanced non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Fudan University | Conditions: THE Efficacy and Safety of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED